Document is current
Any future updates will be listed below
-
Authors
Pan, Ingrid https://orcid.org/0009-0008-4755-0639
Lin, Clara
Palestine, Alan G.
Edwards Mayhew, Rebecca G.
Jung, Jennifer L.
- License Information
-
More Information
Article History
Received: 12 September 2025
Accepted: 30 October 2025
First Online: 23 November 2025
Declarations
:
: Ingrid Pan has served as consultant for Pharming Pharmaceuticals and Sobi—Swedish Orphan Biovitrium AB (Sobi) and currently serves as a consultant for Wolters Kluwer Clinical Drug Information, Inc—Lexicomp ® . Alan G. Palestine serves as a consultant for Tarsier Pharma. Clara Lin has served as a consultant for Pharming Pharmaceuticals. Rebecca G. Edwards Mayhew and Jennifer L. Jung declare that they have no competing interests. Alan G. Palestine is an Editorial Board member of Ophthalmology and Therapy . Alan G. Palestine was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This study was approved by the Colorado Multiple Institutional Review Board (21-3192) and followed the tenets of the Declaration of Helsinki and the Health Insurance Portability and Accountability Act of 1996 (HIPAA). The requirement of informed consent was waived, as this study was retrospective. Patients were not involved in the study trial design or dissemination of results.
